Table 16 |
||||||||||||||||||
|
Interval containing all the 19 cases in the test set and none of the 78 cases in the training set |
||||||||||||||||||
|
Gene Accession Number |
AB033007 |
NM_001661 |
NM_001756 |
AF148505 |
Contig42421_RC |
NM_003748 |
NM_020974 |
AL080059 |
AL110129 |
Contig15031_RC |
Contig65439 |
Contig37063_RC |
Contig41383_RC |
AL049689 |
Contig63102_RC |
Contig55574_RC |
Contig38451_RC |
|
|
|
||||||||||||||||||
|
Interval |
Lower bound |
-0.212 |
-0.227 |
-0.541 |
-0.268 |
-0.301 |
-0.295 |
-1.085 |
-0.606 |
-0.144 |
-0.282 |
-0.325 |
-0.307 |
-0.106 |
-0.219 |
-0.347 |
-0.325 |
-0.245 |
|
Upper bound |
0.187 |
0.017 |
0.29 |
0.22 |
0.394 |
0.309 |
0.557 |
0.401 |
0.241 |
0.062 |
0.303 |
0.272 |
0.117 |
0.304 |
0.331 |
0.576 |
0.183 |
|
|
|
||||||||||||||||||
|
Alexe et al. Breast Cancer Research 2006 8:R41 doi:10.1186/bcr1512 |
||||||||||||||||||
